nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CA—colon cancer	0.49	0.896	CbGaD
Caffeine—ABCB1—colon cancer	0.0572	0.105	CbGaD
Caffeine—CYP3A7—Irinotecan—colon cancer	0.0216	0.106	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0216	0.106	CbGbCtD
Caffeine—CYP3A7—Vincristine—colon cancer	0.0189	0.093	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0189	0.093	CbGbCtD
Caffeine—CYP2C9—Capecitabine—colon cancer	0.0176	0.0866	CbGbCtD
Caffeine—CYP3A5—Irinotecan—colon cancer	0.0162	0.0798	CbGbCtD
Caffeine—CYP2C8—Fluorouracil—colon cancer	0.0149	0.0736	CbGbCtD
Caffeine—CYP3A5—Vincristine—colon cancer	0.0142	0.0697	CbGbCtD
Caffeine—CYP1A2—Fluorouracil—colon cancer	0.0116	0.057	CbGbCtD
Caffeine—ABCB1—Irinotecan—colon cancer	0.0105	0.0519	CbGbCtD
Caffeine—CYP2C9—Fluorouracil—colon cancer	0.0104	0.0514	CbGbCtD
Caffeine—ABCB1—Vincristine—colon cancer	0.00921	0.0454	CbGbCtD
Caffeine—CYP3A4—Irinotecan—colon cancer	0.00631	0.0311	CbGbCtD
Caffeine—ABCB1—Methotrexate—colon cancer	0.00558	0.0275	CbGbCtD
Caffeine—CYP3A4—Vincristine—colon cancer	0.00552	0.0272	CbGbCtD
Caffeine—Necrotizing enterocolitis—Capecitabine—colon cancer	0.00474	0.107	CcSEcCtD
Caffeine—Necrotising enterocolitis neonatal—Capecitabine—colon cancer	0.00474	0.107	CcSEcCtD
Caffeine—Necrotising colitis—Capecitabine—colon cancer	0.00388	0.0876	CcSEcCtD
Caffeine—Ca++ increased—Capecitabine—colon cancer	0.00356	0.0805	CcSEcCtD
Caffeine—PIK3CD—endothelium—colon cancer	0.0029	0.0391	CbGeAlD
Caffeine—PIK3CD—blood vessel—colon cancer	0.00267	0.0361	CbGeAlD
Caffeine—PIK3CB—endothelium—colon cancer	0.00253	0.0341	CbGeAlD
Caffeine—PIK3CA—endothelium—colon cancer	0.0025	0.0338	CbGeAlD
Caffeine—PIK3CB—blood vessel—colon cancer	0.00233	0.0315	CbGeAlD
Caffeine—PIK3CA—blood vessel—colon cancer	0.00231	0.0312	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vincristine—colon cancer	0.00219	1	CbGdCrCtD
Caffeine—ATM—embryo—colon cancer	0.0018	0.0243	CbGeAlD
Caffeine—PIK3CD—embryo—colon cancer	0.00159	0.0215	CbGeAlD
Caffeine—ATM—epithelium—colon cancer	0.00147	0.0198	CbGeAlD
Caffeine—PIK3CB—embryo—colon cancer	0.00139	0.0188	CbGeAlD
Caffeine—PIK3CA—embryo—colon cancer	0.00138	0.0186	CbGeAlD
Caffeine—ATM—renal system—colon cancer	0.00136	0.0184	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—colon cancer	0.00134	0.0181	CbGeAlD
Caffeine—PIK3CD—epithelium—colon cancer	0.0013	0.0176	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—colon cancer	0.00125	0.0169	CbGeAlD
Caffeine—Cerebral haemorrhage—Vincristine—colon cancer	0.00124	0.028	CcSEcCtD
Caffeine—PIK3CD—renal system—colon cancer	0.00121	0.0163	CbGeAlD
Caffeine—PIK3CB—epithelium—colon cancer	0.00113	0.0153	CbGeAlD
Caffeine—ATM—lymphoid tissue—colon cancer	0.00113	0.0153	CbGeAlD
Caffeine—PIK3CA—epithelium—colon cancer	0.00112	0.0152	CbGeAlD
Caffeine—ATM—digestive system—colon cancer	0.00112	0.0151	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—colon cancer	0.00109	0.0148	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—colon cancer	0.00108	0.0146	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—colon cancer	0.00108	0.0146	CbGeAlD
Caffeine—PIK3CB—renal system—colon cancer	0.00105	0.0142	CbGeAlD
Caffeine—PIK3CA—renal system—colon cancer	0.00104	0.0141	CbGeAlD
Caffeine—ATM—bone marrow—colon cancer	0.00103	0.0139	CbGeAlD
Caffeine—PIK3CD—lymphoid tissue—colon cancer	0.001	0.0135	CbGeAlD
Caffeine—PIK3CD—digestive system—colon cancer	0.00099	0.0134	CbGeAlD
Caffeine—ATM—vagina—colon cancer	0.000986	0.0133	CbGeAlD
Caffeine—PRKDC—bone marrow—colon cancer	0.000973	0.0131	CbGeAlD
Caffeine—PRKDC—vagina—colon cancer	0.000932	0.0126	CbGeAlD
Caffeine—PIK3CD—bone marrow—colon cancer	0.000912	0.0123	CbGeAlD
Caffeine—PIK3CB—lymphoid tissue—colon cancer	0.000874	0.0118	CbGeAlD
Caffeine—PIK3CA—lymphoid tissue—colon cancer	0.000865	0.0117	CbGeAlD
Caffeine—PIK3CB—digestive system—colon cancer	0.000863	0.0117	CbGeAlD
Caffeine—PIK3CA—digestive system—colon cancer	0.000854	0.0115	CbGeAlD
Caffeine—ATM—liver—colon cancer	0.000831	0.0112	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—colon cancer	0.000796	0.0108	CbGeAlD
Caffeine—PIK3CB—bone marrow—colon cancer	0.000796	0.0107	CbGeAlD
Caffeine—PIK3CA—bone marrow—colon cancer	0.000788	0.0106	CbGeAlD
Caffeine—PRKDC—liver—colon cancer	0.000786	0.0106	CbGeAlD
Caffeine—Impaired healing—Methotrexate—colon cancer	0.000769	0.0174	CcSEcCtD
Caffeine—PIK3CB—vagina—colon cancer	0.000762	0.0103	CbGeAlD
Caffeine—RYR1—vagina—colon cancer	0.000755	0.0102	CbGeAlD
Caffeine—PIK3CA—vagina—colon cancer	0.000755	0.0102	CbGeAlD
Caffeine—Accidental injury—Irinotecan—colon cancer	0.000754	0.017	CcSEcCtD
Caffeine—PIK3CD—liver—colon cancer	0.000737	0.00996	CbGeAlD
Caffeine—Haemoglobin decreased—Capecitabine—colon cancer	0.000649	0.0147	CcSEcCtD
Caffeine—PIK3CB—liver—colon cancer	0.000643	0.00869	CbGeAlD
Caffeine—Hypercalcaemia—Capecitabine—colon cancer	0.000643	0.0145	CcSEcCtD
Caffeine—ATM—lymph node—colon cancer	0.000637	0.00861	CbGeAlD
Caffeine—RYR1—liver—colon cancer	0.000637	0.0086	CbGeAlD
Caffeine—PIK3CA—liver—colon cancer	0.000637	0.0086	CbGeAlD
Caffeine—Urine output increased—Vincristine—colon cancer	0.00062	0.014	CcSEcCtD
Caffeine—PRKDC—lymph node—colon cancer	0.000603	0.00814	CbGeAlD
Caffeine—Sepsis—Irinotecan—colon cancer	0.000579	0.0131	CcSEcCtD
Caffeine—PIK3CD—lymph node—colon cancer	0.000565	0.00764	CbGeAlD
Caffeine—Deafness—Vincristine—colon cancer	0.000556	0.0126	CcSEcCtD
Caffeine—ADORA2B—vagina—colon cancer	0.000555	0.0075	CbGeAlD
Caffeine—Sepsis—Fluorouracil—colon cancer	0.000555	0.0125	CcSEcCtD
Caffeine—ADORA1—renal system—colon cancer	0.000551	0.00744	CbGeAlD
Caffeine—ADORA2A—lymphoid tissue—colon cancer	0.00053	0.00715	CbGeAlD
Caffeine—Injury—Irinotecan—colon cancer	0.000527	0.0119	CcSEcCtD
Caffeine—PIK3CB—lymph node—colon cancer	0.000493	0.00666	CbGeAlD
Caffeine—PIK3CA—lymph node—colon cancer	0.000488	0.00659	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.000484	0.0109	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.000464	0.0105	CcSEcCtD
Caffeine—Blood creatinine increased—Irinotecan—colon cancer	0.000454	0.0103	CcSEcCtD
Caffeine—Irritability—Fluorouracil—colon cancer	0.000443	0.01	CcSEcCtD
Caffeine—Dry skin—Fluorouracil—colon cancer	0.000425	0.00961	CcSEcCtD
Caffeine—CYP3A7—liver—colon cancer	0.000419	0.00566	CbGeAlD
Caffeine—Urine output increased—Capecitabine—colon cancer	0.000404	0.00912	CcSEcCtD
Caffeine—ADORA1—vagina—colon cancer	0.000399	0.00539	CbGeAlD
Caffeine—ADORA2A—liver—colon cancer	0.00039	0.00526	CbGeAlD
Caffeine—Sepsis—Capecitabine—colon cancer	0.000388	0.00876	CcSEcCtD
Caffeine—Renal failure—Irinotecan—colon cancer	0.000367	0.00829	CcSEcCtD
Caffeine—CYP1B1—smooth muscle tissue—colon cancer	0.000363	0.0049	CbGeAlD
Caffeine—Deafness—Capecitabine—colon cancer	0.000362	0.00819	CcSEcCtD
Caffeine—Infestation NOS—Fluorouracil—colon cancer	0.000358	0.00808	CcSEcCtD
Caffeine—Infestation—Fluorouracil—colon cancer	0.000358	0.00808	CcSEcCtD
Caffeine—CYP3A7-CYP3A51P—liver—colon cancer	0.000356	0.00481	CbGeAlD
Caffeine—CYP1B1—renal system—colon cancer	0.000349	0.00471	CbGeAlD
Caffeine—PDE4B—lymphoid tissue—colon cancer	0.000338	0.00457	CbGeAlD
Caffeine—Haemoglobin—Irinotecan—colon cancer	0.000337	0.00761	CcSEcCtD
Caffeine—Haemorrhage—Irinotecan—colon cancer	0.000335	0.00757	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000324	0.00733	CcSEcCtD
Caffeine—Haemoglobin—Fluorouracil—colon cancer	0.000323	0.00729	CcSEcCtD
Caffeine—Haemorrhage—Fluorouracil—colon cancer	0.000321	0.00725	CcSEcCtD
Caffeine—Cardiac disorder—Vincristine—colon cancer	0.000319	0.00722	CcSEcCtD
Caffeine—Cardiac disorder—Irinotecan—colon cancer	0.000311	0.00703	CcSEcCtD
Caffeine—Irritability—Capecitabine—colon cancer	0.000309	0.00699	CcSEcCtD
Caffeine—PDE4B—bone marrow—colon cancer	0.000308	0.00416	CbGeAlD
Caffeine—Blood creatinine increased—Capecitabine—colon cancer	0.000304	0.00686	CcSEcCtD
Caffeine—Immune system disorder—Irinotecan—colon cancer	0.000303	0.00684	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—colon cancer	0.000301	0.00679	CcSEcCtD
Caffeine—Dry skin—Capecitabine—colon cancer	0.000297	0.00671	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—colon cancer	0.000296	0.00669	CcSEcCtD
Caffeine—PDE4B—vagina—colon cancer	0.000295	0.00398	CbGeAlD
Caffeine—CYP1B1—lymphoid tissue—colon cancer	0.00029	0.00391	CbGeAlD
Caffeine—Sepsis—Methotrexate—colon cancer	0.000289	0.00652	CcSEcCtD
Caffeine—Gastritis—Capecitabine—colon cancer	0.000287	0.00648	CcSEcCtD
Caffeine—CYP1B1—digestive system—colon cancer	0.000286	0.00387	CbGeAlD
Caffeine—ABCB1—blood vessel—colon cancer	0.000284	0.00383	CbGeAlD
Caffeine—Agitation—Vincristine—colon cancer	0.000275	0.00622	CcSEcCtD
Caffeine—CYP2C8—renal system—colon cancer	0.000267	0.00361	CbGeAlD
Caffeine—CYP1A1—epithelium—colon cancer	0.000266	0.00359	CbGeAlD
Caffeine—Convulsion—Vincristine—colon cancer	0.00026	0.00586	CcSEcCtD
Caffeine—Hypertension—Vincristine—colon cancer	0.000259	0.00584	CcSEcCtD
Caffeine—ADORA1—lymph node—colon cancer	0.000258	0.00348	CbGeAlD
Caffeine—Hyperglycaemia—Capecitabine—colon cancer	0.000253	0.00571	CcSEcCtD
Caffeine—Hypertension—Irinotecan—colon cancer	0.000252	0.00569	CcSEcCtD
Caffeine—CYP1A2—renal system—colon cancer	0.00025	0.00338	CbGeAlD
Caffeine—Infestation NOS—Capecitabine—colon cancer	0.00025	0.00565	CcSEcCtD
Caffeine—Infestation—Capecitabine—colon cancer	0.00025	0.00565	CcSEcCtD
Caffeine—PDE4B—liver—colon cancer	0.000249	0.00336	CbGeAlD
Caffeine—CYP1A1—renal system—colon cancer	0.000247	0.00333	CbGeAlD
Caffeine—Renal failure—Capecitabine—colon cancer	0.000246	0.00555	CcSEcCtD
Caffeine—Infection—Vincristine—colon cancer	0.000243	0.00549	CcSEcCtD
Caffeine—Convulsion—Fluorouracil—colon cancer	0.000242	0.00547	CcSEcCtD
Caffeine—CYP3A5—renal system—colon cancer	0.000241	0.00326	CbGeAlD
Caffeine—Nervous system disorder—Vincristine—colon cancer	0.00024	0.00542	CcSEcCtD
Caffeine—Infection—Irinotecan—colon cancer	0.000237	0.00534	CcSEcCtD
Caffeine—Nervous system disorder—Irinotecan—colon cancer	0.000233	0.00528	CcSEcCtD
Caffeine—Irritability—Methotrexate—colon cancer	0.00023	0.0052	CcSEcCtD
Caffeine—Infection—Fluorouracil—colon cancer	0.000227	0.00512	CcSEcCtD
Caffeine—Haemoglobin—Capecitabine—colon cancer	0.000225	0.00509	CcSEcCtD
Caffeine—CYP2E1—renal system—colon cancer	0.000225	0.00304	CbGeAlD
Caffeine—Haemorrhage—Capecitabine—colon cancer	0.000224	0.00507	CcSEcCtD
Caffeine—Nervous system disorder—Fluorouracil—colon cancer	0.000224	0.00505	CcSEcCtD
Caffeine—Tachycardia—Fluorouracil—colon cancer	0.000223	0.00503	CcSEcCtD
Caffeine—CYP1B1—liver—colon cancer	0.000213	0.00288	CbGeAlD
Caffeine—Dyspnoea—Irinotecan—colon cancer	0.000212	0.0048	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—colon cancer	0.000211	0.00477	CcSEcCtD
Caffeine—Cardiac disorder—Capecitabine—colon cancer	0.000208	0.0047	CcSEcCtD
Caffeine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000206	0.00464	CcSEcCtD
Caffeine—CYP1A2—digestive system—colon cancer	0.000205	0.00277	CbGeAlD
Caffeine—Dyspnoea—Fluorouracil—colon cancer	0.000203	0.00459	CcSEcCtD
Caffeine—Immune system disorder—Capecitabine—colon cancer	0.000203	0.00458	CcSEcCtD
Caffeine—CYP1A1—digestive system—colon cancer	0.000202	0.00273	CbGeAlD
Caffeine—CYP3A5—digestive system—colon cancer	0.000198	0.00267	CbGeAlD
Caffeine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000197	0.00445	CcSEcCtD
Caffeine—Malnutrition—Capecitabine—colon cancer	0.000195	0.00441	CcSEcCtD
Caffeine—CYP2C9—digestive system—colon cancer	0.000195	0.00263	CbGeAlD
Caffeine—CYP2C8—vagina—colon cancer	0.000194	0.00261	CbGeAlD
Caffeine—PDE4B—lymph node—colon cancer	0.000191	0.00258	CbGeAlD
Caffeine—CYP2E1—lymphoid tissue—colon cancer	0.000187	0.00252	CbGeAlD
Caffeine—Infestation NOS—Methotrexate—colon cancer	0.000186	0.0042	CcSEcCtD
Caffeine—Infestation—Methotrexate—colon cancer	0.000186	0.0042	CcSEcCtD
Caffeine—CYP2E1—digestive system—colon cancer	0.000185	0.00249	CbGeAlD
Caffeine—Renal failure—Methotrexate—colon cancer	0.000183	0.00413	CcSEcCtD
Caffeine—CYP3A4—renal system—colon cancer	0.000181	0.00245	CbGeAlD
Caffeine—Hypersensitivity—Vincristine—colon cancer	0.00018	0.00407	CcSEcCtD
Caffeine—CYP1A1—vagina—colon cancer	0.000179	0.00241	CbGeAlD
Caffeine—CYP2D6—renal system—colon cancer	0.000178	0.00241	CbGeAlD
Caffeine—Hypersensitivity—Irinotecan—colon cancer	0.000175	0.00396	CcSEcCtD
Caffeine—CYP3A5—vagina—colon cancer	0.000175	0.00236	CbGeAlD
Caffeine—ABCB1—embryo—colon cancer	0.000169	0.00229	CbGeAlD
Caffeine—Hypertension—Capecitabine—colon cancer	0.000169	0.00381	CcSEcCtD
Caffeine—Hypersensitivity—Fluorouracil—colon cancer	0.000168	0.0038	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—colon cancer	0.000168	0.00379	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—colon cancer	0.000167	0.00377	CcSEcCtD
Caffeine—CYP1B1—lymph node—colon cancer	0.000164	0.00221	CbGeAlD
Caffeine—CYP2C8—liver—colon cancer	0.000163	0.00221	CbGeAlD
Caffeine—Infection—Capecitabine—colon cancer	0.000158	0.00358	CcSEcCtD
Caffeine—Nervous system disorder—Capecitabine—colon cancer	0.000156	0.00353	CcSEcCtD
Caffeine—Tachycardia—Capecitabine—colon cancer	0.000156	0.00351	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—colon cancer	0.000155	0.0035	CcSEcCtD
Caffeine—Skin disorder—Capecitabine—colon cancer	0.000155	0.0035	CcSEcCtD
Caffeine—Rash—Vincristine—colon cancer	0.000154	0.00348	CcSEcCtD
Caffeine—Dermatitis—Vincristine—colon cancer	0.000154	0.00348	CcSEcCtD
Caffeine—CYP1A2—liver—colon cancer	0.000153	0.00206	CbGeAlD
Caffeine—Immune system disorder—Methotrexate—colon cancer	0.000151	0.00341	CcSEcCtD
Caffeine—CYP1A1—liver—colon cancer	0.000151	0.00204	CbGeAlD
Caffeine—Rash—Irinotecan—colon cancer	0.00015	0.00339	CcSEcCtD
Caffeine—Dermatitis—Irinotecan—colon cancer	0.00015	0.00339	CcSEcCtD
Caffeine—CYP3A4—digestive system—colon cancer	0.000149	0.00201	CbGeAlD
Caffeine—CYP3A5—liver—colon cancer	0.000147	0.00199	CbGeAlD
Caffeine—CYP2D6—digestive system—colon cancer	0.000146	0.00197	CbGeAlD
Caffeine—Malnutrition—Methotrexate—colon cancer	0.000145	0.00328	CcSEcCtD
Caffeine—CYP2C9—liver—colon cancer	0.000145	0.00196	CbGeAlD
Caffeine—Rash—Fluorouracil—colon cancer	0.000144	0.00325	CcSEcCtD
Caffeine—Dermatitis—Fluorouracil—colon cancer	0.000144	0.00325	CcSEcCtD
Caffeine—Dyspnoea—Capecitabine—colon cancer	0.000142	0.00321	CcSEcCtD
Caffeine—ABCB1—epithelium—colon cancer	0.000138	0.00187	CbGeAlD
Caffeine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000138	0.00311	CcSEcCtD
Caffeine—CYP2E1—liver—colon cancer	0.000138	0.00186	CbGeAlD
Caffeine—ABCB1—renal system—colon cancer	0.000128	0.00173	CbGeAlD
Caffeine—Convulsion—Methotrexate—colon cancer	0.000126	0.00285	CcSEcCtD
Caffeine—Infection—Methotrexate—colon cancer	0.000118	0.00266	CcSEcCtD
Caffeine—Hypersensitivity—Capecitabine—colon cancer	0.000117	0.00265	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—colon cancer	0.000116	0.00263	CcSEcCtD
Caffeine—CYP1A1—lymph node—colon cancer	0.000116	0.00156	CbGeAlD
Caffeine—Skin disorder—Methotrexate—colon cancer	0.000115	0.0026	CcSEcCtD
Caffeine—CYP3A4—liver—colon cancer	0.000111	0.00149	CbGeAlD
Caffeine—CYP2D6—liver—colon cancer	0.000109	0.00147	CbGeAlD
Caffeine—ABCB1—lymphoid tissue—colon cancer	0.000106	0.00144	CbGeAlD
Caffeine—Dyspnoea—Methotrexate—colon cancer	0.000106	0.00239	CcSEcCtD
Caffeine—ABCB1—digestive system—colon cancer	0.000105	0.00142	CbGeAlD
Caffeine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000102	0.00231	CcSEcCtD
Caffeine—Rash—Capecitabine—colon cancer	0.0001	0.00227	CcSEcCtD
Caffeine—Dermatitis—Capecitabine—colon cancer	0.0001	0.00227	CcSEcCtD
Caffeine—ABCB1—bone marrow—colon cancer	9.69e-05	0.00131	CbGeAlD
Caffeine—ABCB1—vagina—colon cancer	9.28e-05	0.00125	CbGeAlD
Caffeine—Hypersensitivity—Methotrexate—colon cancer	8.74e-05	0.00197	CcSEcCtD
Caffeine—ABCB1—liver—colon cancer	7.83e-05	0.00106	CbGeAlD
Caffeine—Rash—Methotrexate—colon cancer	7.48e-05	0.00169	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—colon cancer	7.47e-05	0.00169	CcSEcCtD
Caffeine—ABCB1—lymph node—colon cancer	6e-05	0.000811	CbGeAlD
Caffeine—PIK3CD—Disease—HRAS—colon cancer	6.21e-06	4.8e-05	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—AKT1—colon cancer	6.18e-06	4.78e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CASP3—colon cancer	6.18e-06	4.78e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—SRC—colon cancer	6.18e-06	4.78e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CASP3—colon cancer	6.13e-06	4.73e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—SRC—colon cancer	6.06e-06	4.68e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ABCB1—colon cancer	6.03e-06	4.66e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—VEGFA—colon cancer	6.02e-06	4.65e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCND1—colon cancer	6.02e-06	4.65e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCND1—colon cancer	5.96e-06	4.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CTNNB1—colon cancer	5.96e-06	4.61e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.96e-06	4.61e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—KRAS—colon cancer	5.95e-06	4.6e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NRAS—colon cancer	5.95e-06	4.59e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—AKT1—colon cancer	5.94e-06	4.59e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—TYMS—colon cancer	5.93e-06	4.58e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CTNNB1—colon cancer	5.9e-06	4.56e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.9e-06	4.56e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HRAS—colon cancer	5.86e-06	4.53e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PIK3CA—colon cancer	5.85e-06	4.52e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—PIK3CA—colon cancer	5.84e-06	4.52e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NRAS—colon cancer	5.83e-06	4.51e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CDKN1A—colon cancer	5.82e-06	4.5e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—PIK3CA—colon cancer	5.77e-06	4.46e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CDKN1A—colon cancer	5.77e-06	4.46e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.76e-06	4.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—EGFR—colon cancer	5.75e-06	4.45e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—APC—colon cancer	5.71e-06	4.41e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—NRAS—colon cancer	5.71e-06	4.41e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—AKT1—colon cancer	5.67e-06	4.38e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PIK3CA—colon cancer	5.62e-06	4.35e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—AKT1—colon cancer	5.61e-06	4.34e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EP300—colon cancer	5.54e-06	4.28e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MYC—colon cancer	5.54e-06	4.28e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TGFB1—colon cancer	5.52e-06	4.27e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EP300—colon cancer	5.49e-06	4.24e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—AKT1—colon cancer	5.48e-06	4.24e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KRAS—colon cancer	5.44e-06	4.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MYC—colon cancer	5.43e-06	4.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TGFB1—colon cancer	5.42e-06	4.19e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—colon cancer	5.42e-06	4.19e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—colon cancer	5.41e-06	4.18e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—colon cancer	5.41e-06	4.18e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SRC—colon cancer	5.39e-06	4.16e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—colon cancer	5.36e-06	4.15e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—colon cancer	5.34e-06	4.13e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SRC—colon cancer	5.34e-06	4.13e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—colon cancer	5.31e-06	4.11e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—AKT1—colon cancer	5.26e-06	4.06e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—colon cancer	5.25e-06	4.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—EP300—colon cancer	5.22e-06	4.03e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CASP3—colon cancer	5.21e-06	4.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—colon cancer	5.2e-06	4.02e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—colon cancer	5.2e-06	4.02e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—AKT1—colon cancer	5.19e-06	4.01e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NRAS—colon cancer	5.18e-06	4.01e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—AKT1—colon cancer	5.18e-06	4e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CASP3—colon cancer	5.15e-06	3.98e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NRAS—colon cancer	5.13e-06	3.97e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—colon cancer	5.12e-06	3.95e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—colon cancer	5.07e-06	3.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.06e-06	3.91e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.06e-06	3.91e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—colon cancer	5.06e-06	3.91e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CTNNB1—colon cancer	5.02e-06	3.88e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—colon cancer	5.02e-06	3.88e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—colon cancer	5.01e-06	3.87e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—PIK3CA—colon cancer	4.97e-06	3.84e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CTNNB1—colon cancer	4.96e-06	3.83e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—AKT1—colon cancer	4.92e-06	3.8e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—colon cancer	4.91e-06	3.8e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CDKN1A—colon cancer	4.9e-06	3.79e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PIK3CA—colon cancer	4.9e-06	3.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CASP3—colon cancer	4.87e-06	3.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.87e-06	3.76e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CDKN1A—colon cancer	4.85e-06	3.75e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—colon cancer	4.83e-06	3.73e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TGFB1—colon cancer	4.82e-06	3.72e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.8e-06	3.71e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—colon cancer	4.78e-06	3.7e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—colon cancer	4.78e-06	3.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—colon cancer	4.77e-06	3.69e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TGFB1—colon cancer	4.77e-06	3.69e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—colon cancer	4.74e-06	3.67e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—colon cancer	4.72e-06	3.65e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—colon cancer	4.72e-06	3.65e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PIK3CA—colon cancer	4.7e-06	3.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—colon cancer	4.7e-06	3.63e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—colon cancer	4.68e-06	3.62e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EP300—colon cancer	4.67e-06	3.61e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—colon cancer	4.66e-06	3.6e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.64e-06	3.59e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—colon cancer	4.62e-06	3.57e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EP300—colon cancer	4.61e-06	3.56e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—colon cancer	4.59e-06	3.55e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CDKN1A—colon cancer	4.59e-06	3.55e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—colon cancer	4.55e-06	3.51e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SRC—colon cancer	4.54e-06	3.51e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PIK3CA—colon cancer	4.51e-06	3.49e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SRC—colon cancer	4.48e-06	3.47e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—colon cancer	4.47e-06	3.45e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—colon cancer	4.46e-06	3.45e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—colon cancer	4.42e-06	3.42e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—colon cancer	4.42e-06	3.42e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—colon cancer	4.37e-06	3.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—colon cancer	4.37e-06	3.38e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—colon cancer	4.37e-06	3.37e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EP300—colon cancer	4.37e-06	3.37e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—colon cancer	4.36e-06	3.37e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—colon cancer	4.35e-06	3.36e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—colon cancer	4.31e-06	3.33e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TYMS—colon cancer	4.29e-06	3.32e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TYMS—colon cancer	4.28e-06	3.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—colon cancer	4.27e-06	3.3e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SRC—colon cancer	4.24e-06	3.28e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.21e-06	3.26e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—colon cancer	4.2e-06	3.24e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—colon cancer	4.17e-06	3.23e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—colon cancer	4.13e-06	3.2e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—colon cancer	4.12e-06	3.18e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.1e-06	3.17e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—colon cancer	4.1e-06	3.17e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—colon cancer	4.08e-06	3.16e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—colon cancer	4.08e-06	3.15e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—colon cancer	4.07e-06	3.14e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—colon cancer	4.06e-06	3.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—colon cancer	4.06e-06	3.14e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TGFB1—colon cancer	4.06e-06	3.14e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TYMS—colon cancer	4.05e-06	3.13e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—colon cancer	4.02e-06	3.11e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—colon cancer	4.02e-06	3.11e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFB1—colon cancer	4.01e-06	3.1e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—colon cancer	4e-06	3.09e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—colon cancer	3.98e-06	3.07e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—colon cancer	3.96e-06	3.06e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—colon cancer	3.93e-06	3.04e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—colon cancer	3.93e-06	3.04e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—colon cancer	3.91e-06	3.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—colon cancer	3.88e-06	3e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.86e-06	2.98e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—colon cancer	3.84e-06	2.97e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—colon cancer	3.8e-06	2.94e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFB1—colon cancer	3.79e-06	2.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—colon cancer	3.79e-06	2.93e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—colon cancer	3.79e-06	2.93e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.78e-06	2.92e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—colon cancer	3.78e-06	2.92e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—colon cancer	3.77e-06	2.91e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—colon cancer	3.76e-06	2.9e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—colon cancer	3.76e-06	2.9e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—colon cancer	3.72e-06	2.88e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—colon cancer	3.71e-06	2.87e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TYMS—colon cancer	3.71e-06	2.87e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—colon cancer	3.69e-06	2.85e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—colon cancer	3.66e-06	2.83e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EP300—colon cancer	3.6e-06	2.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—colon cancer	3.51e-06	2.72e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—colon cancer	3.5e-06	2.71e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—colon cancer	3.45e-06	2.67e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—colon cancer	3.41e-06	2.64e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—colon cancer	3.41e-06	2.64e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—colon cancer	3.37e-06	2.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—colon cancer	3.35e-06	2.59e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—colon cancer	3.34e-06	2.58e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—colon cancer	3.32e-06	2.56e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—colon cancer	3.3e-06	2.55e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—colon cancer	3.3e-06	2.55e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—colon cancer	3.23e-06	2.5e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.23e-06	2.5e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—colon cancer	3.19e-06	2.47e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—colon cancer	3.16e-06	2.44e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—colon cancer	3.15e-06	2.44e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.14e-06	2.43e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—colon cancer	3.14e-06	2.43e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—colon cancer	3.13e-06	2.42e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—colon cancer	3.12e-06	2.41e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.12e-06	2.41e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—colon cancer	3.1e-06	2.4e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—colon cancer	3.07e-06	2.38e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—colon cancer	3.07e-06	2.37e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—colon cancer	3.05e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—colon cancer	3.05e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—colon cancer	3.04e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—colon cancer	3.03e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—colon cancer	3.02e-06	2.33e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—colon cancer	2.99e-06	2.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—colon cancer	2.9e-06	2.24e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—colon cancer	2.87e-06	2.22e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.86e-06	2.21e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—colon cancer	2.82e-06	2.18e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—colon cancer	2.79e-06	2.15e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—colon cancer	2.75e-06	2.12e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.69e-06	2.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—colon cancer	2.67e-06	2.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—colon cancer	2.64e-06	2.04e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—colon cancer	2.63e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—colon cancer	2.63e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—colon cancer	2.58e-06	1.99e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—colon cancer	2.58e-06	1.99e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—colon cancer	2.47e-06	1.91e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—colon cancer	2.39e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—colon cancer	2.39e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.32e-06	1.8e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—colon cancer	2.29e-06	1.77e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—colon cancer	2.26e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—colon cancer	2.25e-06	1.74e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—colon cancer	2.18e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—colon cancer	2.16e-06	1.67e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—colon cancer	2.14e-06	1.65e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—colon cancer	2.07e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—colon cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—colon cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—colon cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—colon cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—colon cancer	1.99e-06	1.53e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—colon cancer	1.88e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—colon cancer	1.84e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—colon cancer	1.83e-06	1.41e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—colon cancer	1.8e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—colon cancer	1.72e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—colon cancer	1.7e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—colon cancer	1.68e-06	1.3e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—colon cancer	1.66e-06	1.28e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—colon cancer	1.5e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—colon cancer	1.47e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—colon cancer	1.47e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—colon cancer	1.44e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—colon cancer	1.41e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—colon cancer	1.41e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—colon cancer	1.4e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—colon cancer	1.39e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—colon cancer	1.27e-06	9.83e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—colon cancer	1.2e-06	9.29e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—colon cancer	1.2e-06	9.27e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—colon cancer	1.2e-06	9.24e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—colon cancer	1.13e-06	8.76e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—colon cancer	1.11e-06	8.58e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—colon cancer	1.11e-06	8.57e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.04e-06	8.07e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—colon cancer	1.04e-06	8.03e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—colon cancer	1.04e-06	8e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—colon cancer	9.23e-07	7.13e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—colon cancer	9.05e-07	7e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—colon cancer	8.85e-07	6.84e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—colon cancer	8.53e-07	6.59e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—colon cancer	8.46e-07	6.54e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—colon cancer	7.23e-07	5.59e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—colon cancer	6.83e-07	5.28e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—colon cancer	5.58e-07	4.31e-06	CbGpPWpGaD
